Charles Elliott Sigal - 30 May 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Issuer symbol
VIR
Transactions as of
30 May 2024
Net transactions value
$0
Form type
4
Filing time
03 Jun 2024, 12:18:50 UTC
Previous filing
20 May 2024
Next filing
12 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +8,000 +51% $0.000000 23,806 30 May 2024 Direct
holding VIR Common Stock 10,000 30 May 2024 By Sigal Family Investments, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +16,000 $0.000000 16,000 30 May 2024 Common Stock 16,000 $10.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.